Market Place
Sourcing Support
Strides Pharma Science Ltd leads losers in `A` group
04 Dec 2024 //
BUSINESS STD
Successful completion of fund raising of USD 95 Mn by Onesource
25 Nov 2024 //
PRESS RELEASE
OneSource Pharma Raises Rs 801 Cr via Equity Issuance
25 Nov 2024 //
BUSINESS STD
Strides Pharma rises 4% after NCLT nods creation of OneSource
21 Nov 2024 //
BUSINESS STD
Strides Pharma jumps on securing NCLT nod for OneSource
21 Nov 2024 //
BUSINESS STD
NCLT Approval for creation OneSource India’s 1st Specialty CDMO
19 Nov 2024 //
PRESS RELEASE
India Advances Epilepsy Treatment with New Drugs & Surgical Options
16 Nov 2024 //
PHARMABIZ
Strides Pharma Reports Q2 FY25 Consolidated PAT of Rs. 93.23 Cr
28 Oct 2024 //
#N/A
Strides Pharma reports Q2 FY25 consolidated PAT at Rs. 93.23 Cr
24 Oct 2024 //
PRESS RELEASE
OneSource receives equity of Rs 8,010 Mn at a pre-money equity
18 Oct 2024 //
PRESS RELEASE
OneSource unveils new brand identity at CPHI Milan
10 Oct 2024 //
INDPHARMAPOST
OneSource in talks to raise Rs 1,670 crore in pre-listing round
26 Sep 2024 //
ECONOMICTIMES
Strides Pharma subsidiary receives USFDA approval for 60 mg Fluoxetine tablets
18 Sep 2024 //
EXPRESSPHARMA
Strides secures shareholders` nod for OneSource specialty CDMO unit
11 Sep 2024 //
ECONOMICTIMES
Proxy advisors vote against Strides Pharma’s consolidation scheme
09 Sep 2024 //
ECONOMICTIMES
Strides gets USFDA nod for Theophylline extended-release tablets
07 Sep 2024 //
ECONOMICTIMES
Strides Pharma`s Generics Theophylline Receives Approval in US
05 Sep 2024 //
FDA
Strides Alathur receives EIR from USFDA for its Chennai facility
19 Aug 2024 //
PRESS RELEASE
Strides Pharma posts Q1 FY25 PAT at Rs. 68.3 Cr
01 Aug 2024 //
INDIANPHARMAPOST
Newspaper-Unaudited Financial Results for the quarter ended June 30, 2024
30 Jul 2024 //
PRESS RELEASE
Strides Pharma Updates On Scheme With Steriscience & Onesource Under Companies
30 Jul 2024 //
PRESS RELEASE
Incorporation of Step-down Wholly Owned Subsidiary in New Zealand
27 Jul 2024 //
PRESS RELEASE
Newspaper Adve– Audited FYR for quarter & financial year ended March 31, 2024
23 May 2024 //
PRESS RELEASE
Strides receives USFDA approval for Sucralfate OralSuspension, 1gm/10 mL
23 May 2024 //
PRESS RELEASE
Strides receives USFDA approval for Sucralfate Oral Suspension, 1gm/10 Ml
22 May 2024 //
PRESS RELEASE
Disposal of Corporate Insolvency Process against Strides Alathur Private Limited
22 May 2024 //
PRESS RELEASE
Outcome of Board Meeting – Audited Financial Results March 31, 2024
22 May 2024 //
PRESS RELEASE
Strides receives USFDA approval for Sevelamer Carbonate Tablets
10 May 2024 //
PRESS RELEASE
Strides Pharma gets USFDA nod for antidepressant medication
09 Apr 2024 //
PRESS RELEASE
Completion of US-FDA Inspection at the Formulations Facility of Strides Alathur
06 Apr 2024 //
PRESS RELEASE
Strides receives USFDA approval for Gabapentin
05 Mar 2024 //
PRESS RELEASE
Intimation under Regulation 30 of Update on divestment of Eris Pharma
02 Feb 2024 //
PRESS RELEASE
Enforcement Report - Week of January 31, 2024
31 Jan 2024 //
FDA
Appointment of Mr. Ameet P Hariani as Independent Director of the Company
30 Jan 2024 //
PRESS RELEASE
Strides reports strong Q3FY24 Revenue and EBITDA
30 Jan 2024 //
PRESS RELEASE
Strides Pharma`s Generic Pregabalin Receives Approval in the U.S.
24 Jan 2024 //
FDA
Strides Pharma Science to invest in AMP-6, AMP-8
03 Jan 2024 //
INDIAN PHARMA POST
Strides Science extends guarantee to Trinity Pharma Proprietary’s borrowing
21 Dec 2023 //
INDIAN PHARMA POST
Strides launches Icosapent Ethyl Acid Soft Gel capsules in
02 Dec 2023 //
INDIAN PHARMA POST
Strides Pharma to sell its Singapore manufacturing facility for $15 million
27 Oct 2023 //
ENDPTS
Strides Pharma to spin off contract development unit
25 Sep 2023 //
ECONOMIC TIMES
Strides Pharma arm gets USFDA nod for generic Mycophenolate Mofetil oral sus
31 Aug 2023 //
ECONOMICTIMES
Enforcement Report - Week of July 12, 2023
12 Jul 2023 //
FDA
Strides sells arm`s manufacturing unit to Syngene International for Rs 702 crore
05 Jul 2023 //
ECONOMIC TIMES
Strides and Orbicular enter into a strategic partnership for nasal sprays
04 May 2023 //
INDIANPHARMAPOST
Strides Pharma`s Kauliv (teriparatide) Receives Approval in Europe
07 Mar 2023 //
EMA
Strides Pharma`s Approved Kauliv ( Teriparatide) In Europe
07 Mar 2023 //
EMA
Strides Pharma Global receives AUD 94 mn for sale of Australia`s operations
23 Dec 2022 //
INDIANPHARMAPOST
Strides Pharma Arms Gets USFDA Approval For Potassium-Deficiency Drug
18 Nov 2022 //
ECONOMICTIMES
US layoffs for Avanir, Strides; Sanofi to cut force in Korea
02 Nov 2022 //
FIERCEPHARMA
Strides Pharma subsidiary gets USFDA nod for drug product capabilities
01 Sep 2022 //
CNBC TV18
Strides Pharma gets USFDA nod for anti-inflammatory drug
18 Aug 2022 //
BUSINESS-STANDARD
Enforcement Report - Week of August 17, 2022
17 Aug 2022 //
FDA
Strides Pharma`s Cyclosporine A Receives BLA Approval in the U.S.
02 Aug 2022 //
FDA
Strides Pharma Arm Gets EU-GMP Certification For Two Facilities
16 Jun 2022 //
OUTLOOKINDIA
Strides gets USFDA nod for generic drug with 180-day exclusivity
11 Jun 2022 //
ET HEALTH
Strides pharma Generic Ibuprofen Receives Approval in the U.S.
09 Jun 2022 //
FDA
Enforcement Report - Week of June 8, 2022
08 Jun 2022 //
FDA
Strides Pharma Gets USFDA Nod for Colchicine Tablets
12 Mar 2022 //
MEDICAL DIALOGUES
